Market Place
Sourcing Support
Glenmark arm recalls products in US for manufacturing issues
13 Oct 2024 //
ECONOMICTIMES
Enforcement Report - Week of October 9, 2024
09 Oct 2024 //
FDA
Enforcement Report - Week of October 2, 2024
02 Oct 2024 //
FDA
Ichnos-Glenmark Antibody Outperforms J&J`s Tecvayli In Mice Study
17 Sep 2024 //
FIERCE BIOTECH
Glenmark to pay USD 25 mn as part of settlement with US authorities
05 Sep 2024 //
ECONOMICTIMES
Glenmark Launches OTC Olopatadine Hydrochloride Ophthalmic Solution
19 Aug 2024 //
PR NEWSWIRE
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
19 Aug 2024 //
INDIANPHARMAPOST
Glenmark Pharma reports Q1 FY25 consolidated PAT at Rs. 340.2 Cr
15 Aug 2024 //
INDIANPHARMAPOST
Enforcement Report for Week of August 7, 2024
07 Aug 2024 //
FDA
Enforcement Report - Week of July 24, 2024
24 Jul 2024 //
FDA
Glenmark Pharma gets USFDA nod for seizure treatment drug
17 Jul 2024 //
MONEYCONTROL
Glenmark and IADVL undertake awareness campaign to support Vitiligo in India
26 Jun 2024 //
PHARMABIZ
Glenmark recalls 114 batches of low potassium drug in the US
26 Jun 2024 //
FIERCE PHARMA
Glenmark USA Issues Voluntary Nationwide Recall for KCL ER Capsule
26 Jun 2024 //
FDA
Glenmark gets USFDA nod to market generic drug
12 Jun 2024 //
ECONOMICTIMES
Glenmark`s Generic Esomeprazole Magnesium Receives Approval in US
11 Jun 2024 //
FDA
Glenmark Pharma concludes Hypertension Awareness Month in India
29 May 2024 //
PHARMABIZ
Glenmark unit ties up with BeiGene to market cancer drugs in India
21 May 2024 //
MONEYCONTROL
Glenmark amplifies Nationwide Heart Health ‘India First Heart First’ campaign
18 May 2024 //
PHARMABIZ
Glenmark receives ANDA approval for Brimonidine Tartrate & Timolol Maleate
18 May 2024 //
INDINPHARMAPOST
Glenmark receives US FDA approval for brimonidine tartrate and timolol maleate
17 May 2024 //
PHARMABIZ
Glenmark launches next phase of ‘India First Heart First’ campaign
17 May 2024 //
INDINPHARMAPOST
Cipla and Glenmark initiate recall of certain products in the US
06 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Enforcement Report - Week of May 1, 2024
01 May 2024 //
FDA
Glenmark Pharma gets USFDA nod for generic anti-inflammatory drug
29 Apr 2024 //
ECONOMICTIMES
Glenmark recalls 6,528 bottles of blood pressure drug in US
15 Apr 2024 //
ECONOMICTIMES
Lupin, Glenmark recall drugs in US market: USFDA
10 Apr 2024 //
MONEYCONTROL
Enforcement Report - Week of April 10, 2024
10 Apr 2024 //
FDA
Delhi High Court seeks response from govt, NPPA on Glenmark`s plea
09 Apr 2024 //
ECONOMIC TIMES
Maharashtra FDA begins probe stickering & mislabelling on Glenmark`s drug Telma
05 Apr 2024 //
DERUG CONTROL
Glenmark Pharma posts Q3 FY24 net loss of Rs. 331 Cr
15 Feb 2024 //
INDIAN PHARMA POST
India`s Glenmark Pharma posts loss for Q3 as remediation cost weighs
14 Feb 2024 //
REUTERS
Glenmark partners with Pfizer to launch abrocitinib in India
31 Jan 2024 //
ECONOMIC TIMES
Enforcement Report - Week of January 31, 2024
31 Jan 2024 //
FDA
Ichnos and Glenmark take a collaborative leap
30 Jan 2024 //
PR NEWSWIRE
Glenmark bags subcutaneous checkpoint inhibitor rights
25 Jan 2024 //
FIERCE BIOTECH
Glenmark inks licensing pact with Jiangsu Alphamab, 3D Medicines for cancer drug
25 Jan 2024 //
ECONOMIC TIMES
Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India
03 Jan 2024 //
INDIAN PHARMA POST
Glenmark launches antidiabetic drug in India
03 Jan 2024 //
ECONOMIC TIMES
Enforcement Report - Week of December 6, 2023
06 Dec 2023 //
FDA
Enforcement Report - Week of November 29, 2023
29 Nov 2023 //
FDA
DKSH and Glenmark Partner to Enrich People’s Lives in Vietnam
28 Nov 2023 //
PRESS RELEASE
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr
13 Nov 2023 //
INDIAN PHARMA POST
India`s Glenmark Pharma posts Q2 loss on exceptional legal costs
10 Nov 2023 //
REUTERS
Enforcement Report - Week of November 8, 2023
08 Nov 2023 //
FDA
Glenmark to launch Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin
18 Oct 2023 //
INDIAN PHARMA POST
Cosmo and Glenmark announce the signing of Agreements for Winlevi
27 Sep 2023 //
PR NEWSWIRE
Glenmark addresses debt with $681M sale of API unit to Nirma
22 Sep 2023 //
FIERCE PHARMA
Glenmark, Baxter issue separate recalls for hypertension and cancer drugs
29 Aug 2023 //
ECONOMIC TIMES
Glenmark to pay $30M in antitrust settlement in US over cholesterol drug pricing
23 Aug 2023 //
ECONOMICS TIMES
Enforcement Report - Week of July 26, 2023
26 Jul 2023 //
FDA
HC restrains Glenmark from selling asthma drug under `Indamet` name
04 Jul 2023 //
ECONOMIC TIMES
Miller Law& Motley Ric Announce a Proposed Settlement Zetia Antitrust Litigation
27 Jun 2023 //
PR NEWSWIRE
Glenmark`s manufacturing facility in Monroe gets USFDA warning letter
22 Jun 2023 //
CNBCTV18
Glenmark Pharma slashes price of breast cancer drug Trastuzumab
15 Jun 2023 //
ECONOMIC TIMES
Glenmark reports Rs 403 crore loss in Q4FY23
19 May 2023 //
ECONOMIC TIMES
Merck, Glenmark put their Zetia antitrust case to bed
25 Apr 2023 //
FIERCE PHARMA
